Better Plant Sciences Inc. — Board/Management Information 2020

Aug 4, 2020

Form 51-102F3 Material Change Report

Item 1: Name and Address of Company

The Yield Growth Corp. (the “ Issuer ”) Suite 200 – 1238 Homer Street Vancouver, BC V6B 2Y5

Item 2: Date of Material Change

July 31, 2020

Item 3: News Release

A news release was issued and disseminated on August 4, 2020 via www.baystreet.com and www.stockwatch.com and filed on SEDAR at www.sedar.com.

Item 4: Summary of Material Change

On July 31, 2020, the Issuer appointed Spiros Margaris as Chair of the Issuer’s Audit Committee. Mr. Margaris has served as an independent director of the Issuer for two years.

Additionally on July 31, 2020, the Issuer appointed Cole Drezdoff to the Board of Directors the Issuer and as an independent member of the Issuer’s Audit Committee.

Item 5: Full Description of Material Change

Please see the news releases attached hereto as Schedule “A”.

Item 6: Reliance on subsection 7.1(2) of National Instrument 51-102

Not applicable.

Item 7: Omitted Information

None.

Item 8: Executive Officer

Penny White, CEO and President Telephone: (833) 514-2677

Item 9: Date of Report

August 4, 2020

Schedule “A”

News Release attached as the following pages.

==> picture [260 x 95] intentionally omitted <==

Yield Growth’s Appoints Spiros Margaris as Audit Committee Chair and appoints Director

August 4, 2020 – Vancouver, BC: The Yield Growth Corp. (CSE:BOSS) (OTCQB:BOSQF) (FE:YG3) (the “Company”) is pleased to announce that Spiros Margaris has been appointed Chair of the Company’s audit committee. The Company also announces the appointment of a new director, Cole Drezdoff, who has also been appointed as a member of the Company’s audit committee.

Spiros Margaris has been a director of the Company for 2 years. He is a thought leader in the FinTech, blockchain and InsurTech industries, and was ranked No. 1 global influencer by Onalytica across all three categories. He is a frequent speaker at international FinTech and InsurTech conferences and is published widely as a thought leader in innovation. Mr. Margaris has over 25 years of financial experience in investment management and financial statement analysis and is the founder of Margaris Ventures, a venture capital and advisory firm, and was previously a partner and member of the Investment Committee of the hedge fund advisory firm Crossbow Partners AG. At Margaris Ventures, Mr. Margaris has served as its Chief Investment Officer since September, 2010. Mr. Margaris holds a Master’s in Business Administration from the University of Toronto.

Cole Drezdoff has developed experience over the past 5 years as a consultant in social media, sales, investor relations and business development. He is financially literate, having recently completed 3 years of full-time accounting and marketing courses at Ryerson University at the Ted Rogers School of Management. As a social media consultant, he was successful in significantly growing follower base, reach, and influence of brands using influencer marketing.

Yield Growth director Spiros Margaris commented: “I am very pleased to welcome Cole Drezdoff to our board of directors. We are excited about the fresh perspective that Cole brings to our board, with his recent experience and education in social media. Yield Growth intends to leverage the recent monumental increase in online and digital activities by driving consumer sales on our ecommerce platform through increased influencer marketing.”

According to research by Global WebIndex in its Digital 2020 July Global Snapshot, more than half the world now uses social media, 4.57 billion people around the world use the internet, and of those users, 346 million new users have come online within the last 12 months.

About The Yield Growth Corp.

The Yield Growth Corp. (CSE: BOSS),(OTCQB: BOSQF) is a phytoceutical and consumer packaged goods company that develops and acquires intellectual property and other assets related to plant-based products and therapeutics, and develops, manufactures, markets, sells and distributes plant-based products that improve lives. It has over 200 proprietary wellness formulas at various stages of commercialization, including over 20 products that are now for sale through e-commerce or brick and mortar retail stores. It has 14 patent applications filed in what the Global Wellness Institute reports is a $4.2 trillion-dollar global wellness market. Its majority owned subsidiary NeonMind Biosciences Inc. is launching a line of medicinal mushroom products and is developing intellectual property in the emerging area of psychedelic medicine. The Yield Growth management team has deep experience with global brands including Johnson & Johnson, Procter & Gamble, Skechers and Aritzia.

Investor Relations Contacts:

Penny White, President & CEO

Kevan Matheson, Investor Relations

invest@yieldgrowth.com

1-833-514- BOSS 1-833-514-2677

1-833-515- BOSS 1-833-515-2677

The Canadian Securities Exchange has not reviewed, approved or disapproved the contents of this news release.

Cautionary Statement Regarding Forward-Looking Statements

This press release includes forward-looking information and statements (collectively, “forward looking statements”) under applicable Canadian securities legislation. Forward-looking statements are necessarily based upon a number of estimates, forecasts, beliefs and assumptions that, while considered reasonable, are subject to known and unknown risks, uncertainties, and other factors which may cause actual results and future events to differ materially from those expressed or implied by such forward-looking statements. Such risks,

uncertainties and factors include, but are not limited to: risks related to the development, testing, licensing, brand development, availability of packaging, intellectual property protection, reduced global commerce and reduced access to raw materials and other supplies do to the spread of the Coronavirus, the potential for not acquiring any rights as a result of the patent application and any products making use of the intellectual property may be ineffective or the company may be unsuccessful in commercializing them; and other approvals will be required before commercial exploitation of the intellectual property can happen. Demand for the company’s products, general business, economic, competitive, political and social uncertainties, delay or failure to receive board or regulatory approvals where applicable, and the state of the capital markets. Yield Growth cautions readers not to place undue reliance on forward-looking statements provided by Yield Growth, as such forward-looking statements are not a guarantee of future results or performance and actual results may differ materially. The forward-looking statements contained in this press release are made as of the date of this press release, and Yield Growth expressly disclaims any obligation to update or alter statements containing any forward-looking information, or the factors or assumptions underlying them, whether as a result of new information, future events or otherwise, except as required by law.